Trials / Completed
CompletedNCT06115408
Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This 2 arm randomized clinical trial will assess the impact of Dienogest and N-Acetyl Cysteine on volume reduction of uterine leiomyoma
Detailed description
Group A women will receive Dienogest orally 2mg pills daily for 3 months .20 cases Group B women will receive NAC orally at a dose of 600 mg/day for 3 months ,20 cases
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dienogest 2 MG | Clinical trial |
| DRUG | N-acetyl cysteine | Clinical trial |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2024-08-31
- Completion
- 2024-08-31
- First posted
- 2023-11-03
- Last updated
- 2024-12-16
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06115408. Inclusion in this directory is not an endorsement.